Cargando…

1224. Outcomes of Empirical Vancomycin De-escalation Based on Methicillin-Resistant Staphylococcus aureus Nares

BACKGROUND: Vancomycin is a first-line therapy for methicillin-resistant Staphylococcus aureus (MRSA) infections. Studies found that vancomycin is associated with a higher incidence of nephrotoxicity, even within therapeutic range. MRSA nares screening allows for rapid identification of MRSA carrier...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jiachen, Chan, Arthur, Wattengel, Bethany A, Mergenhagen, Kari A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677569/ http://dx.doi.org/10.1093/ofid/ofad500.1064

Ejemplares similares

571. Determining the Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening in Antimicrobial Stewardship
por: Mergenhagen, Kari A, et al.
Publicado: (2019)

Use of nares swab to de-escalate vancomycin for patients with suspected methicillin-resistant Staphylococcus aureus
por: Gentges, Joshua, et al.
Publicado: (2023)

78. Impact of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Screen on Vancomycin Utilization for Respiratory Tract Infections
por: Debnath, Ashita, et al.
Publicado: (2021)

1073. Predictors of Vancomycin Switch or Escalation in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
por: Lagnf, Abdalhamid M, et al.
Publicado: (2018)

87. Utilization of Methicillin-Sensitive/Resistant Staphylococcus aureus Nares Screen to Decrease Vancomycin and Linezolid Use in Hospitalized Patients with Respiratory Infections
por: Zaidan, Noor F, et al.
Publicado: (2020)

2068. Outpatient Antimicrobial Stewardship: Optimizing Patient Care Via Pharmacist Led Culture Review
por: Wattengel, Bethany A, et al.
Publicado: (2019)

301 Risk of Methicillin-Resistant Staphylococcus aureus Infection in Patients with Intermittent vs Persistent Nares Colonization
por: Vigil, Daniel I., et al.
Publicado: (2014)

1138. Utility of Methicillin-resistant Staphylococcus aureus Nares Screening in Hospitalized Children With Acute Infectious Disease Syndromes
por: Sands, Ashley, et al.
Publicado: (2021)

The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy
por: Chotiprasitsakul, Darunee, et al.
Publicado: (2017)

1651. Utility of Staphylococcus aureus Nares Screening in Hospitalized Children with Osteomyelitis
por: Sands, Ashley, et al.
Publicado: (2023)

167. Duration of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares PCR Positivity while Receiving Highly Active Anti-Staphylococcal Drugs
por: Wu, Maximillian S, et al.
Publicado: (2023)

2807. Using Less of Our Big Guns: Vancomycin De-Escalation Using Methicillin-Resistant Staphylococcus aureus Nasal Swab Screening Protocol
por: Sittirat, Petchpailin D, et al.
Publicado: (2023)

176. Evaluation of the Predictive Value of Methicillin-Resistant Staphylococcus aureus (MRSA) Nares Polymerase Chain Reaction (PCR) Screening within Hospitalized Patients
por: Alilaen, Nicole, et al.
Publicado: (2022)

1266. Refining Antimicrobial Stewardship by De-escalating Vancomycin Using MRSA (Methicillin Resistant Staphylococcus aureus) Nasal Screening in a Community Hospital Setting
por: Shah, Ruta, et al.
Publicado: (2023)

1448. Impact of Mental Illness on Outcomes of Outpatients with Community-Acquired Pneumonia
por: Mergenhagen, Kari, et al.
Publicado: (2018)

1465. Discovering Outpatient Stewardship Targets: An Evaluation of Community Acquired Pneumonia in the Outpatient Setting
por: Wattengel, Bethany, et al.
Publicado: (2018)

1113. Outpatient Antimicrobial Stewardship: Targets for Urinary Tract Infections
por: Mergenhagen, Kari A, et al.
Publicado: (2019)

1466. Alkaline Urine: A Cause for Urinary Tract Infection Recurrence
por: Wattengel, Bethany A, et al.
Publicado: (2019)

1422. Evaluation of Diabetic Foot Infections and Osteomyelitis in a Veteran Population: Targets for Improved Outcomes
por: Carter, Michael T, et al.
Publicado: (2019)

Vancomycin (VAN) Combinations with Β-Lactams (BLs) against Methicillin-Resistant Staphylococcus aureus (MRSA), Heterogeneous Intermediate-Level Resistance to Vancomycin (hVISA) and Vancomycin-Intermediate Staphylococcus aureus (VISA)
por: Tran, Kieu-Nhi, et al.
Publicado: (2017)

Effectiveness of Daptomycin in Patients with Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia Despite Vancomycin
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2017)

2250. Combination Vancomycin Plus Cefazolin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections
por: Jorgensen, Sarah C J, et al.
Publicado: (2019)

1224. Drug-Resistance Dynamics of Staphylococcus aureus at a Tertiary Hospital, Beijing, China: 2013–2017
por: Zhang, Yuzheng, et al.
Publicado: (2018)

Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015)

Utility of Methicillin-Resistant Staphylococcus aureus Nares Screening in Hospitalized Children with Acute Infectious Disease Syndromes
por: Sands, Ashley, et al.
Publicado: (2021)

2129. When Is Methicillin-resistant Staphylococcus aureus not Methicillin-resistant Staphylococcus aureus?
por: Gitman, Melissa R, et al.
Publicado: (2019)

2003. Vancomycin Discontinuation Is Supported by-negative Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) in Patients with Pneumonia
por: Pleasants, Katherine A, et al.
Publicado: (2019)

1062. Daptomycin/Ceftaroline in Combination vs. Vancomycin for the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Fox, Matthew, et al.
Publicado: (2018)

1033. Unexpected Allies: Vancomycin and Cefazolin Combination Therapy in Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Caniff, Kaylee E, et al.
Publicado: (2023)

187. Vancomycin Plus Ceftaroline Salvage Therapy for Persistent Methicillin-Resistant Staphylococcus aureus Bacteremia
por: Kufel, Wesley D, et al.
Publicado: (2021)

Combination Vancomycin/Cefazolin (VAN/CFZ) for Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections (BSI)
por: Trinh, Trang D, et al.
Publicado: (2017)

1588. Delafloxacin Activity Against Staphylococcus aureus with Reduced Susceptibility or Resistance to Methicillin, Vancomycin, Daptomycin, or Linezolid
por: Saravolatz, Louis D, et al.
Publicado: (2019)

Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004)

Vancomycin Susceptibility within Methicillin-resistant Staphylococcus aureus Lineages
por: Howe, Robin A., et al.
Publicado: (2004)

276. Comparison of Ceftaroline in Combination with Either Vancomycin or Daptomycin for the Treatment of Methicillin-resistant Staphylococcus aureus Bacteremia
por: Welch, Stephanie N, et al.
Publicado: (2020)

Effect of the Methicillin-Resistant Staphylococcus aureus Nasal Polymerase Chain Reaction on Vancomycin Days and Clinical Outcomes in Pneumonia
por: Hendon, Natalie, et al.
Publicado: (2017)

The Association of Molecular Characteristics, Vancomycin MIC and Clinical Outcomes in Methicillin-susceptible Staphylococcus aureus Osteoarticular Infections in Children
por: McNeil, Jonathon, et al.
Publicado: (2017)

204. Antagonistic Effect of Colistin on Vancomycin Activity Against Methicillin-Resistant Staphylococcus aureus in in vitro and in vivo Studies
por: Choi, Sungim, et al.
Publicado: (2019)

227. Evaluation of Empiric Vancomycin Utilization at 72 Hours Post Admission: is De-escalation of Vancomycin Appropriate?
por: Naderi, Mandana, et al.
Publicado: (2020)

Methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in Taiwan
por: Lin, Chien-Yu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_jpup60hlvbbc47h2rehpcnl7jv